Home/Filings/4/0001209191-21-069547
4//SEC Filing

Vaddi Krishna 4

Accession 0001209191-21-069547

CIK 0001678660other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 5:36 PM ET

Size

8.8 KB

Accession

0001209191-21-069547

Insider Transaction Report

Form 4
Period: 2021-12-13
Vaddi Krishna
DirectorCEO
Transactions
  • Award

    Common Stock

    2021-12-13$12.13/sh+8,000$97,0351,053,519 total
Holdings
  • Common Stock

    (indirect: By Trust)
    423,655
  • Common Stock

    (indirect: By Trust)
    551,774
  • Common Stock

    (indirect: By Trust)
    551,774
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.01 to $12.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
  • [F2]Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.
  • [F3]The Reporting Person is the investment advisor of the Blue Sky Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
  • [F4]The Reporting Person is the investment advisor of the Brocade Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
  • [F5]The Reporting Person is a beneficiary of the Dolphin City Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Issuer

Prelude Therapeutics Inc

CIK 0001678660

Entity typeother

Related Parties

1
  • filerCIK 0001824633

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 5:36 PM ET
Size
8.8 KB